Antonio Miranda‐Duarte

ORCID: 0000-0001-6530-4636
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Osteoarthritis Treatment and Mechanisms
  • Muscle Physiology and Disorders
  • Neurogenetic and Muscular Disorders Research
  • Bone health and osteoporosis research
  • Bone Metabolism and Diseases
  • Spine and Intervertebral Disc Pathology
  • Musculoskeletal pain and rehabilitation
  • Genomics and Rare Diseases
  • Cancer-related gene regulation
  • Retinal Diseases and Treatments
  • Tracheal and airway disorders
  • Congenital heart defects research
  • Epigenetics and DNA Methylation
  • Knee injuries and reconstruction techniques
  • Shoulder Injury and Treatment
  • Estrogen and related hormone effects
  • Bipolar Disorder and Treatment
  • Connective tissue disorders research
  • Receptor Mechanisms and Signaling
  • Genetic Neurodegenerative Diseases
  • Cardiomyopathy and Myosin Studies
  • RNA modifications and cancer
  • Orthopedic Surgery and Rehabilitation
  • Cancer-related molecular mechanisms research
  • MicroRNA in disease regulation

Instituto Nacional de Rehabilitación
2016-2025

Universidade Tuiuti do Paraná
2024

National Institute of Genomic Medicine
2023

Genethon (France)
2023

Genomic (Brazil)
2022

VA Caribbean Healthcare System
2021

Centro Hospitalar de Entre o Douro e Vouga E.P.E.
2021

Universidad Politécnica de Madrid
2021

Algarve Biomedical Center
2017

Utrecht University
2015

Objective To analyze a set of circulating microRNA (miRNA) in plasma from patients with primary Osteoarthritis (OA) and describe the biological significance altered miRNA OA based on an silico analysis their target genes. Methods expression was analyzed using TaqMan Low Density Arrays independent assays. The search for potential messenger RNA (mRNA) targets differentially expressed performed by means miRWalk miRecords database; we conducted relevance predicted pathway Reactome DAVID...

10.1371/journal.pone.0097690 article EN cc-by PLoS ONE 2014-06-05

Although substantial advancements have been made in genetic testing, several barriers continue to limit patient access, leading delays diagnosis, effective treatments, and preventative measures. The NEUROMYODredger-3billion Megaproject End the Diagnostic Odyssey grant offered free whole exome sequencing (WES) 245 patients with undiagnosed neurodevelopmental or neuromuscular disorders seven countries: Algeria, Chile, Egypt, France, Mexico, Peru, Romania. We found pathogenic variants 79...

10.1111/cge.14736 article EN cc-by Clinical Genetics 2025-02-25

Abstract A 41‐year‐old man had ichthyosis, ectropion, steatorrhea, and slowly progressive proximal limb weakness. Biopsies showed abnormal lipid accumulation in muscle, liver, skin, leukocytes, gastric mucosa. Lipid storage was particularly marked cultures of skin it increased subsequent cell generations. By electron microscopy, the globules no limiting membranes. The stored identified by thin‐layer chromatography as triglyceride; there excess cholesterol or cholesteryl esters. Muscle...

10.1002/mus.880020102 article EN Muscle & Nerve 1979-01-01

Obtaining a perfect color match with resin composite presents significant challenge. The chameleon effect has enabled to mimic the of adjacent tooth structure in vitro. This double-blind, split-mouth and equivalent randomized clinical trial evaluated matching one-shade versus multi-shade non-carious cervical lesion restorations (NCCLs). One hundred twenty were performed on NCCLs two restorative materials (n = 60). After prophylaxis, teeth isolated rubber dam one universal adhesive was...

10.1186/s12903-024-05108-6 article EN cc-by-nc-nd BMC Oral Health 2024-12-04

Pompe disease (PD) is a neuromuscular disorder caused by acid α-glucosidase (GAA) deficiency. Reduced GAA activity leads to pathological glycogen accumulation in cardiac and skeletal muscles responsible for severe heart impairment, respiratory defects, muscle weakness. Enzyme replacement therapy with recombinant human (rhGAA) the standard-of-care treatment PD, however, its efficacy limited due poor uptake development of an immune response. Multiple clinical trials are ongoing PD...

10.1002/jimd.12625 article EN cc-by-nc-nd Journal of Inherited Metabolic Disease 2023-05-19

Purpose: Pseudoexfoliation syndrome (XFS) is a major risk factor for exfoliation glaucoma (XFG). A significant association exists between XFG and several SNPs in the lysyl oxidase-like 1 (LOXL1) gene. The purpose of this study was to report results first LOXL1 polymorphisms XFS and/or Latin American population.Methods: Genotypes three high-risk (rs1048661, rs3825942, rs2165241) were analyzed by direct sequencing. case-control conducted with 102 unrelated XFS/XFG Mexican patients (42 XFS/60...

10.3109/13816810.2011.615078 article EN Ophthalmic Genetics 2011-10-04

Fear-avoidance beliefs are related to the prognosis of chronicity in low back pain subacute stages, however chronic pain, is no clear influence these factors; it has been suggested that study population can determine magnitude on disability and those suffering from pain. Currently, information does not exist Mexican population.To analyze relationship between fear-avoidance with Mexicans pain; potentials differences subgroups according time evolution.Cross-sectional LBP aged 18 45. Data were...

10.1016/j.rbre.2016.11.003 article EN cc-by-nc-nd Revista Brasileira de Reumatologia (English Edition) 2016-12-08

Diagnosis of developmental dysplasia the hip (DDH) mostly relies on physical examination and ultrasound, both methods are operator-dependent. Late detection can lead to complications in young adults. Current evidence supports involvement environmental genetic factors, such as single nucleotide variants (SNVs). Incorporating factors into diagnostic would be useful for implementing early management affected individuals. Our aim was analyze SNVs DDH patients. We included 287 cases 284 controls....

10.3390/diagnostics14090898 article EN cc-by Diagnostics 2024-04-25

The growth of SJL B cell lymphomas (RCS, reticulum sarcoma) in vivo and vitro is known to depend on cytokine production by RCS-responsive host CD4+ T cells. high frequency RCS responsive cells normal lymph nodes prompted us prepare a set 21 RCS-specific hybridomas. Like cells, these hybridoma respond RCS, but not syngeneic cells; produce IL-2, IL-4, IL-5; promote gamma-irradiated hosts. A superantigen-like stimulation was borne out the fact that all hybridomas used V beta 16 their TCR. did...

10.4049/jimmunol.150.12.5519 article EN The Journal of Immunology 1993-06-15

Limb-Girdle Muscular Dystrophy type 2 (LGMD2) is a group of autosomally recessive inherited disorders defined by weakness and wasting the shoulder pelvic girdle muscles. In past, several population isolates with high incidence LGMD2 arising from founder mutation effects have been identified. The aim this work to describe results clinical, epidemiologic, molecular studies performed in Mexican village segregating numerous cases LGMD2. A census was conducted identify all LGMD affected patients....

10.1371/journal.pone.0170280 article EN cc-by PLoS ONE 2017-01-19

Aims: To evaluate the role of Langerhans cells (LCs) in local activation leprosy lesions. LCs, acting as tolerance inducers and immune stimuli, are dendritic recently implicated cutaneous homeostasis. The LCs defence against mycobacterial infection remains poorly understood. Methods results: number distribution CD1a+ skin HLA‐DR intercellular adhesion molecule (ICAM)‐1 expression were analysed lesions delayed‐type hypersensitivity (DTH) tests. results showed a high tuberculin lepromin tests,...

10.1111/j.1365-2559.2007.02848.x article EN other-oa Histopathology 2007-10-09

Abstract Spasticity has been successfully managed with different treatment modalities or combinations. No information is available on the effectiveness individual contribution of botulinum toxin type A (BTA) combined physical and occupational therapy neuromuscular electrical stimulation to treat spastic upper limb. The purpose this study was assess effects such inform sample‐size calculations for a randomized controlled trial. BTA injected into limb muscles 10 children. They received...

10.1111/j.1525-1594.2009.00768.x article EN Artificial Organs 2010-03-01
Coming Soon ...